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AbstrAct
Extracorporeal shock wave therapy (ESWT) is a non-invasive and innovative 
technology for the management of specific tendinopathies. In order to elucidate 
the ESWT-mediated clinical benefits, human Tendon-derived Stem/Progenitor cells 
(hTSPCs) explanted from 5 healthy semitendinosus (ST) and 5 ruptured Achilles 
(AT) tendons were established. While hTSPCs from the two groups showed similar 
proliferation rates and stem cell surface marker profiles, we found that the clonogenic 
potential was maintained only in cells derived from healthy donors. Interestingly, 
ESWT significantly accelerated hTSPCs differentiation, suggesting that the clinical 
benefits of ESWT may be ascribed to increased efficiency of tendon repair after injury.
INtrODUctION
The main cellular component of the human 
tendon consists of tenocytes that represent only the 5% 
of the normal tissue volume and are responsible for 
its maintenance and repair [1]. However, histological 
findings of injured tendons showed the presence of cells 
characterized by several phenotypes, suggesting that a 
possible multilineage differentiation potential may be 
involved either in tissue repair or in pathophysiology 
of such diseases, frequently characterized by fatty 
degeneration and chondroid calcification [2, 3]. On the 
other hand, the recovery of a normal function of injured 
tendons represents an ambitious goal in this field and 
various cell-based therapies with regenerative purpose for 
tendon-related pathologies have been recently performed 
[4-6]. The replacement of injured tenocytes and the 
restoration of a normal tissue homeostasis have been 
efficiently obtained by the injection of mesenchymal stem 
cells (MSCs) in the area of damaged tendons [5, 7].
Pathophysiology of tendinopathy, a degenerative 
disorder of the tendons, is still unclear and a better 
understanding of the cellular mechanisms involved in the 
healing process occurring in this pathology could strongly 
improve its therapeutic management [2]. The tendon 
healing is a multistep process involving inflammatory 
cells, cytokine release, extracellular matrix (ECM) 
remodelling and neoangiogenesis. In fact, tendinopathies 
can also be treated with autologous Platelet-rich plasma 
(PRP), containing large amounts of growth factors, some 
of them favoring tendon healing by cell recruitment and 
differentiation, while its clinical effectiveness remains 
matter of debate [8-10].
ESWT is an alternative treatment of some chronic 
tendinopathies. In order to explain its clinical benefits, 
we recently demonstrated that ESWT enhances cell 
proliferation, migration and secretory activity of human 
primary cultured tenocytes [11-13]. Previous reports 
suggested that the physical stimulation provided by 
shock waves could involve recruitment and further 
differentiation of stem cells [14-17].
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Intriguingly, human Tendon-derived Stem/
Progenitor cells (hTSPCs) were efficiently isolated from 
tendons of various species, including human hamstring 
tendons [18-20]. These local progenitor cells showed a 
self-renewal capacity, the potential to differentiate along 
an assortment of mature cell lineages -including tenocytes 
[21]- and are supposed to enhance tendon repair in several 
models [22-24]. Therefore, it has been recently proposed a 
function of resident stem cells in promoting tendon repair 
[1]. 
In light of those observations, we aimed to 
investigate the possible effects of shock wave exposure 
on hTSPCs explanted from healthy semitendinosus or 
ruptured Achilles tendons. In order to assess the ESWT 
putative burden on cell differentiation, we treated our 
cultures at the optimal dose accurately selected in previous 
investigations [11-13]. Our data show that this treatment 
significantly promotes the in vitro-induced hTSPCs 
differentiation.
rEsULts
st and At cells share similar characteristics
We established 10 different primary cultures of 
human tenocytes, 5 derived from healthy semitendinosus 
(ST) and 5 from ruptured Achilles (AT) tendons (Table 
1), as previously described [12]. Human tendon-derived 
cells, both from ST or AT, were plastic-adherent and after 
2 weeks of culture were subjected to cell characterization. 
In both ST and AT cultures, phase contrast 
microscopy shows heterogeneous cell morphology, 
consisting in two main cellular patterns, as expected [1, 
11, 18, 20, 25]. A prevalent fibroblast-like phenotype, 
spread on the plate and characterized by elongated cell 
bodies with thin processes, alternated with a minority of 
enlarged tenoblast-like cells (Figure 1), which become 
progressively more represented when cultures was 
reaching confluence (data not shown), as previously 
Figure 1: Culture cell characterization shows no significant differences in ST and AT cells. Morphological analysis by phase 
contrast microscopy, vimentin evaluation by immunofluorescence and histograms plots of cell cycle distribution by flow cytometry in ST1 
A. and AT1 B. cultures, representative of healthy and ruptured human tendon-derived cells. Nuclei are stained with DAPI. Bar 10 µm.
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reported [11]. No significant morphological differences 
were detected between ST1-5 and AT1-5 cells (Table 1). 
In order to evaluate possible differences in ST (ST1-
5) and AT (AT1-5) cells, vimentin, a mesenchymal cell 
marker that labels cytoskeleton intermediate filaments, 
was then evaluated by immunofluorescence (Figure 1). 
A positive staining of perinuclear cytoplasmic bundles 
of filaments confirmed unequivocally the mesenchymal 
origin of all our cultures and excluded possible 
derangement of the cells (Table 1).
To evaluate the growth rate of ST (ST1-5) and 
AT (AT1-5) cells, we further analyzed the cell cycle 
distribution by flow cytometry (Table 1 and Figure 1). 
Results in Table 1 showed that both types of cultures were 
characterized by a similar mean percentage of cells in 
G2/M phase (10,34 in healthy ST1-5 and 11,86 in ruptured 
AT1-5), indicating the presence of proliferating cells in all 
our samples. 
clonogenic potential is observed only on healthy 
human semitendinosus-derived cells
Because stem cells typically display clonogenic 
potential, we tried to clone all our 10 primary cultures. 
We observed that they started to proliferate after few days 
of quiescence. Clonogenic cultures were generated by 
diluting suspension (1cell/µl) (as previously described 
[18, 19]) and they appeared heterogeneous in size and cell 
density. Therefore -according to previous authors [26]- we 
considered clones only those with diameter >2mm. In our 
samples, clonogenic potential seemed to be independent 
on tendon-derived patient age, but exclusive of ST cells 
(ranging from 16 to 45 years old, see Table 1): in fact, four 
out of five cultures derived from healthy ST were cloned 
and named ST1-4/C (Figure 2A-2B), but none of the 
cultures from ruptured AT could be cloned (Figure 2C).
Figure 2: Cloning of tendon-derived cells. Cloning of ST1, representative of healthy ST-derived cells, one A. and two B. weeks after 
plating. C. Uncloned AT1, representative of cells derived from ruptured AT, 12 days after plating. Bar: 20 µm.
Figure 3: Expression of the differentiation marker alpha-smooth muscle actin (α-SMA) in healthy ST- and ruptured 
AT-derived cells. A. The α-SMA signal is present in intracellular filaments situated at the cytoplasmic periphery of all the tendon-derived 
cells, here represented by AT1. Nuclei are stained with DAPI. Bar 20µm. B. Quantitative analysis of a-SMA-positive cells in AT, ST and 
ST/C cells reveals a significant increase in ruptured AT compared to healthy ST cells (Mann-Whitney: *p < 0.05 and **p < 0.001 vs ST 
and ST/C respectively). The data are represented with the Tukey box-and-whisker plot; the values are expressed as median ± Interquartile 
Ranges (IR) from three independent experiments.
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Expression of the differentiation marker alpha-
smooth muscle actin (α-SMA) is significantly 
enhanced in uncloned At cells
Considering that several authors reported a depletion 
of stem cell pool and a limited differentiation potential 
due to aging of the donors, for this part of the study we 
selected 6 cultures (ST1-2, the corresponding clones ST1-
2/C and the uncloned AT1-2) derived from the youngest 
donors, ranging from 17 to 25 years old [1, 25, 27, 28]. 
First we evaluated by immunofluorescence the 
expression of α-SMA, which is a differentiation marker 
for activated tenocytes, as previously suggested [29], 
showing a signal localized in intracellular filaments, also 
organized in bundles, situated in the peripheral areas of 
the cytoplasm, (as shown in Figure 3A). Quantitative 
analysis of α-SMA-positive cells revealed an increase of 
differentiation in uncloned AT, especially when compared 
to cloned ST/C, and to a lesser extent to uncloned ST 
cells (Figure 3B), suggesting that these different types of 
cultures are not at the same stage of differentiation.
Figure 4: ST, ST/C and AT cells express typical surface stem cell markers. Typical cell surface markers are analyzed by 
flow cytometry in ST1-2, ST1-2/C and AT1-2 cells. A. The figure shows a representative plots of ST1, ST1/C and AT1 cell cultures. In 
histograms, the curves of surface stem cells markers (in red) are overlayed with the unmarked cells (in blue). B. The cumulative data of stem 
cell markers are represented with the floating bars; the values are expressed as median ± Interquartile Ranges (IR) from three independent 
experiments (Mann-Whitney: *p < 0.05 vs ST and ST/C; ^p=not significant vs ST and ST/C).
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st and At cultures express stem cell-related 
surface markers
In order to better characterize the previously selected 
cultures (ST1-2, ST1-2/C and AT1-2), the expression of 
typical surface stem cell markers was then evaluated by 
flow cytometry. Because no single marker can certainly 
identify human tendon-derived stem or progenitor cells 
[18], a panel of surface antigens was examined and shown 
in Table 2.
FACS analysis showed pretty similar profiles of 
cell surface markers in cells explanted from healthy (ST) 
or ruptured (AT) tendons. All cultures revealed positive 
expression for the fibroblast marker CD90.2 (88 to 
99,9%) and for the putative mesenchymal stem markers 
CD44 (86,7 to 99%) and CD105 (86,2 to 99,9%), and 
were mainly negative for the hematopoietic stem cell 
marker CD34 (1 to 9,6%). Nevertheless, a heterogeneous 
expression for the stem cell marker CD146, which is 
directly linked to multipotency [30], was observed. As 
shown in Figure 4, CD146 values were significantly 
higher in cells derived from healthy, ranging from 36 to 
48,2% in ST1-2 and from 60,5 to 96,2% in corresponding 
clones ST1-2/C, compared to cells derived from ruptured 
samples, ranging in AT1-2 from 8,45 to 9,5% (Figure 4A-
4B).
ESWT enhances proliferation and differentiation 
of ST and AT cells
Firstly, to evaluate the proliferative rate of our 
cultures in response to ESWT, we performed a Ki67 
analysis -a nuclear marker of cycling cells- showing 
significant differences between tendon-derived cells after 
and before cloning, as well as from those derived from 
healthy ST compared to pathological AT tendons (Figure 
supplemental 1A). Quantitative analysis of the percentage 
of Ki67+ cells revealed an ESWT-mediated proliferative 
effect on ST1-2, ST1-2/C, and AT1-2 cultures compared 
with control (p < 0.05). Interestingly, the shock wave-
mediated proliferative effects were evident 12 days after 
the treatment -which is consistent with our previous data 
[11], especially in cloned (ST/C) compared to uncloned 
(ST and AT) cells and in ruptured (AT) versus healthy (ST) 
tendon-derived cells (Figure supplemental 1B).
Then the effect of ESWT on adipogenic, 
chondrogenic and osteogenic differentiation was evaluated 
using specific differentiation culture media (DM) on the 
previously selected 6 cultures. 
Cell morphology was first assessed -by light 
Figure 5: ESWT significantly increases the expression of differentiation markers in cells grown in specific differentiation 
media (DM). The clone ST1/C, representative of hTSPCs is shown for the cytochemical analysis in Figure 5A-5D (Bar: 10µm). 
Cytochemical analysis -by light microscopy- 21 days of DM cell-culture in ESWT pre-treated cells B., D. compared to DM cell culture in 
untreated cells A., C. Results expressed in Figure 5E-F represent the mean value ± SD measured on 10 digital frames for each culture, for 
osteogenic (5A-5B, Alizarin Red depots, *p < 0.05 vs untreated) as well as adipogenic (5C-5D, Oil Red droplets, **p < 0.0005 vs untreated) 
differentiation. 
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microscopy and for few days- during the initial growth. 
Similarly to the results reported in Figure 1, cultured 
cells continued to be relatively heterogeneous, showing 
the same appearance described above. No significant 
morphological differences were observed in ESWT-
treated cultures derived from healthy (ST1-2, ST1-2/C) or 
ruptured tendons (AT1-2) (data not shown). 
The ESWT-mediated response on differentiation was 
further evaluated, upon 21 days in specific differentiation 
media (DM), by cytochemical evaluation of differentiation 
markers performed by the detection of Oil Red positive 
droplets in adipogenic medium cultured cells and Alizarin 
Red positive calcium-rich depots in osteogenic medium 
cultured cells. We never detected neither Oil Red positive 
droplets nor Alizarin Red calcium depots in cells cultured 
in DMEM basal medium. ESWT significantly increased 
the differentiation of ST, ST/C or AT-derived cells, grown 
in specific differentiation media (DM) (Figure 5A-5F). 
As shown in Figure 5, ESWT improved the osteogenic 
(detected by Alizarin Red depots) and the adipogenic 
(detected by Oil Red droplets) differentiation. No 
significant cytochemical differences were observed in 
cloned ST/C compared to uncloned ST1-2 and AT1-2 
cultures, as well as in ST versus AT derived cells, grown 
in DM either pre-treated with ESWT or untreated (data 
not shown). 
Moreover, in order to deeper investigate the cell 
morphology, an ultrastructural analysis by transmission 
electron microscopy (TEM) was performed. The 
substantial heterogeneity in cell appearance previously 
documented by light microscopy was confirmed by TEM 
analysis of ST, ST/C and AT cells, before or after ESWT: 
in fact, while most of them showed thin plasma membrane 
protrusions, others were characterized by an enlarged 
morphology lacking cell processes. Lipid droplets were 
clearly detectable in adipogenic medium-cultured cells 
(Figure 6A), whereas calcium depots are visible in nearby 
osteogenic medium-cultured cells (Figure 6C). The 
cytoplasm of the cells cultured in chondrogenic medium 
was heterogeneously filled with stack of regularly-aligned 
cisternae of rough endoplasmic reticulum and prominent 
Golgi apparatus, indicating their secretory activity (Figure 
6B). 
According to the previous analysis, again no 
significant morphological differences were observed in 
ST, ST/C or AT cultures, either before or after ESWT. 
In addition, TEM confirmed that ESWT enhances the in 
vitro-induced cell differentiation, either to adipogenic or 
osteogenic lineage (data not shown).
The effects of ESWT on differentiation were then 
assessed by RT-PCR -on the 6 cultures as above (ST1-
2, ST1-2/C and AT1-2)- to determine the expression of 
specific genes activated in response to differentiative 
stimuli. COL2A and SOX9 expression was selected to 
analyze the chondrogenic lineage, ALP, BGLAP and 
RUNX2 for the osteogenic lineage, and PPARγ for the 
adipogenic differentiation. Results showed that, after 21 
days of culture, there was an ESWT-mediated significant 
up-regulation in the expression of COL2A and SOX9 
for chondrogenic differentiation, of ALP for osteogenic 
table 1: st and At cells share similar characteristics
Healthy st cells
specimen code Age Fibroblast-like phenotype Vimentin G2/M
st1 16 +++ +++ 11,4
st2 19 +++ +++ 7,5
st3 17 +++ +++ 10,5
st4 45 +++ +++ 11,2
st5 40 ++ +++ 11,1
Mean 27,4 10,34
ruptured At cells 
specimen code Age Fibroblast-like phenotype Vimentin G2/M
At1 19 ++ +++ 9,1
At2 25 +++ +++ 12,1
At3 41 ++ +++ 8,7
At4 56 +++ +++ 12,5
At5 29 ++ +++ 16,9
Mean 34 11,86
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and PPARγ for adipogenic differentiation in all types of 
cells (p < 0.05: ESWT+DM vs DM alone), confirming 
the cytochemical observations (Figure 7A). In contrast, 
the osteogenic markers BGLAP and RUNX2 were not 
significantly different. The gene expression profiles of 
cells cultured in DMEM was used as negative control. 
Again, no significant differences were detectable in 
cultures derived from healthy semitendinosus (ST and 
ST/C) or from ruptured Achilles (AT) tendon explants 
(data not shown). 
Further molecular analysis to control ESWT-
mediated effects was performed in ST, ST/C or AT 
cultures grown 12 days in basal medium, measuring 
mRNA transcript levels of the early differentiation 
tenocyte marker Scleraxis (Scx) (Figure 7B) [31, 32]. 
In untreated samples, Scx expression was significantly 
higher in ruptured AT-derived compared to healthy ST-
derived cells. In ESWT-treated samples, Scx levels were 
significantly increased in ST/C, compared to uncloned ST 
and AT cultures. 
In this work we designated both types of cultures as 
human Tendon-derived Stem/Progenitor cells (hTSPCs), 
according with previous report [18]. 
DIscUssION
In this study, we show that ESWT is able to 
accelerate the in vitro-induced differentiation of human 
primary cultured Tendon Stem/Progenitor cells. In a 
previous study, we demonstrated that ESWT increases 
the functional activities of tenocytes explanted from 
human tendons -including proliferation, migration and 
collagen synthesis- without modifying cell viability [11-
13]. Moreover we also showed that cultures derived from 
ruptured tendons were more susceptible to shock wave-
mediated activation, indicating a possible recruitment of 
undifferentiated progenitors in the site of injury [12, 13]. 
Here we confirm that ESWT induces cell proliferation, 
although our cultures are not at the same stage of 
differentiation, and are characterized by a heterogeneous 
natural differentiation potential, probably initiated by 
tendon injuries [12, 13]. Therefore, according with other 
reports [14, 15, 33], the clinical benefits of ESWT can 
be explained by mechanical stress promoting the in vivo 
regenerative capacity of the tissue. 
However it is widely accepted that physiological 
repair after tendon damage is pretty limited [34]. As 
recently suggested, human stem cells are considered 
a suitable tool for the management of human chronic 
tendinopathies, albeit their effective contribution to tendon 
regeneration in vivo is still matter of discussion [2, 5, 15, 
19, 24, 35, 36 , 37]. Cultures of tendon-derived stem 
cells were established and several reports investigated 
strategies to enhance differentiation into tenocytic-like 
lineage [18, 38, 39]. The International Society for Cellular 
Therapy (ISCT) proposed the minimal criteria to define 
human mesenchymal stem cells (MSCs), including the 
capacity to be plastic-adherent, proliferate, form colonies, 
express typical CD markers and differentiate in vitro to 
osteoblasts, adipocytes and chondroblasts [40]. 
In the present work, we describe these capacities in 
a variable percentage of healthy semitendinosus (ST) and 
ruptured Achilles (AT) human tendon-derived cells that 
we designated as human Tendon-derived Stem/Progenitor 
Cells (hTSPCs), according with previous report [18]. 
Since we published that the in vitro biological behaviour of 
cells explanted from healthy compared to ruptured tendons 
was significantly different [12], possible variations also 
in establishing human tendon-derived stem cells from 
those sources could be expected. Although proliferative 
capacity and multipotency are detectable in all our 
cultures, the clonogenicity potential is exclusive of healthy 
ST-, whereas ruptured AT-derived cells grow separately 
and do not form colonies. Interestingly, the expression 
of α-SMA and Scx tenocytic differentiation markers is 
significantly enhanced in uncloned AT cells, whereas the 
stem cell-related surface marker CD146, probably linked 
to multipotency [30], was significantly higher in ST 
cells. Therefore, although Zhang and colleagues showed 
a different ability to form colonies in tendon progenitor 
cells derived from patellar and Achilles tendons of rabbits 
[19], we previously published that our cell characterization 
showed no significant differences between Achilles and 
semitendinosus tendon-derived cultures [12]. For this 
Table 2: FACS analysis of typical surface stem cell marker expression in ST and AT cells
Surface stem cell markers expression (%) in ST and AT-derived cells
specimen code cD146 cD44 CD90.2 cD105 cD34
st1 36 95,8 99,6 99,6 3 
st2 48,2 99 99,9 97,8 4,4 
st1/c 96,2 93,7 99,9 99,7 1
st2/c 60,5 91,3 99,2 95,8 2 
At1 8,45 96,2 99, 5 99,6 9,6 
At2 9,5 86,7 88 86,2 4,4
Oncotarget6417www.impactjournals.com/oncotarget
Figure 6: Ultrastructural analysis -by TEM- of ESWT-treated hTSPCs. The clone ST1/C, representative of hTSPCs is shown 
for the ultrastructural analysis. A. Electron microscopy analysis shows the presence of lipid droplets (LD) in adipogenic medium-cultured 
hTSPCs (Bar: 2µm). B. hTSPCs grown in chondrogenic medium shows abundant rough Endoplasmic Reticulum (ER) and prominent Golgi 
apparatus (G) (Bar: 500nm). C. Calcium depots (CN: Centers of initial Nucleation) are present in osteogenic medium-cultured hTSPCs 
(Bar: 500nm). Mitochondrion (M), Nucleus (N), Plasma Membrane (PM).
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Figure 7: Molecular analysis of typical differentiation markers -by RT-PCR- of ESWT-treated hTSPCs. A. mRNA 
expression of COL2A, SOX9 (chondrogenic differentiation), ALP (osteogenic differentiation), and PPARγ (adipogenic differentiation) was 
evaluated after 21 days of culture in differentiation media (DM) following or not ESWT in ST/C, ST and AT cells; (*p < 0.01: ESWT+DM 
vs DM; **p < 0.05: DM vs DMEM). Corresponding gene expression in cells cultured in DMEM was used as negative control and values 
were normalized to DMEM, set to 1. B. mRNA expression of Scx (early differentiation marker) was evaluated after 12 days of culture 
in DMEM basal medium ±ESWT. In untreated samples, values were normalized to ST/C cells, set to 1 (*p < 0.005: AT vs ST and ST/C; 
^p=not significant: ST vs ST/C). In ESWT-treated samples, values were normalized to ST cells, set to 1 (*p < 0.0005: ST/C vs AT and ST; 
^p=not significant: AT vs ST).
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reason, we propose that the differences observed in our 
samples may be amenable to the damage occurred in 
human AT and its physiological attempt to repair the 
injury, although we cannot definitively exclude that they 
are due to their different origin.
It is likely that a variable amount of resident 
hTSPCs started a differentiative program to regenerate 
the tissue. Intriguingly, even though uncloned ruptured 
AT cells already started a differentiation program toward 
the tenocytic lineage, all hTSPCs cultures partially 
maintain a multidifferentiative potential, as ascertained 
by their capacity to differentiate in vitro. Although the 
physiological repair of tendons remains difficult, it is 
conceivable that our tendon-derived cells can be facilitated 
by specific treatments, such as ESWT, to differentiate 
toward tenocytic-like lineage. 
Consistent with this hypothesis, we show for the 
first time that ESWT significantly enhances hTSPCs-
induced differentiation, as indicated by cytochemical 
and molecular findings. Our results are mainly in 
agreement with previous reports performed in vitro on 
equine adipose tissue-derived stem cells [41], rat and 
human adipose-derived stem cells [17, 42] and human 
bone marrow stromal cells [15, 16]. Surprisingly, no 
significant differences in the appearance and behavior 
of healthy ST and ST/C compared to AT cells was 
induced by ESWT, implying that the different amount of 
hTSPCs present in both types of explants share similar 
characteristics. Therefore we suppose that in our cultures 
may coexist cellular elements bearing different degrees 
of differentiation, all being sensitive to shock wave 
stimulation. 
Taken together, previous reports and the present 
observations seem to corroborate the long-held idea 
that ESWT may enhance recruitment, proliferation and 
differentiation of tissue-derived stem cells [15, 17, 41]. We 
propose that such treatment, applied on injured tendons, 
is able to accelerate stem cell differentiation -probably 
through the release of different cytokines and growth 
factors- mainly towards tenocytic lineage, contributing to 
tendon repair. 
Further investigations will certainly help to better 
clarify that ESWT clinical benefits are amenable to 
mechanisms triggering tendon healing promoted by 
resident stem cells recruitment.
MATERIALS AND METHODS
Patients
Adult human tendon-derived cells were explanted 
from 5 healthy semitendinosus (ST) tendons of patients 
affected by Anterior Cruciate Ligament (ACL) rupture and 
subjected to ligament reconstruction by ST, and 5 from 
patients affected by Achilles (AT) tendon ruptures. The 
average age of the patients was 31 ± 15 years.
The Institutional Review Board of ‘‘Sapienza’’ 
University and Sant’Andrea Hospital approved the study 
protocol, and all patients gave their written informed 
consent to the experimental study.
Isolation, culture and cloning of tendon-derived 
cells
Freshly isolated tendon-derived cells, from ST 
or AT, were seeded in 24well/plates (or T25 plates) and 
cultured around 3 weeks in conventional medium (DMEM 
with 10% FBS), as described [11-13]. In order to form 
colonies, cells were cultured 8-10 days in Tissue Culture 
Dishes (Corning 100x20mm) after a diluting suspension 
to 1cell/µl, as previously described [18, 19]. Single cell 
colonies, when clearly detectable and more than 2mm in 
diameter, were detached by local application of trypsin, 
transferred to T25 flasks for further culture, rapidly 
proliferated reaching around 80% confluence and finally 
used for the following experiments. Also cells that were 
not able to form colonies were similarly detached and 
cultured, and used for the following experiments. 
Immunofluorescence
Cells grown on coverslips were fixed with 4 % 
paraformaldehyde followed by treatment with 0.1 M 
glycine for 20 min at 25°C and with 0.1 % Triton X-100 
for additional 5 min at 25°C to allow permeabilization. 
Cells were then incubated alternatively with the 
following primary antibodies: the anti-vimentin (1:50 
in PBS; Dako, Glostrup, Denmark) and alpha-smooth 
muscle actin (α-SMA) (1:50 in PBS; Dako) monoclonal 
antibodies and the rabbit polyclonal antibody anti-Ki67 
(1:50; Zymed Laboratories; San Francisco, CA, USA). 
The primary antibodies were visualized, after appropriate 
washing with PBS, by using goat anti-mouse IgG-FITC 
(1:50 in PBS; Cappel Research Products, Durham, NC, 
USA), for 30 min at 25°C and the goat anti-rabbit IgG-
Texas Red (1:200; Jackson Immunoresearch Laboratories, 
West Grove, PA, USA). Nuclei were stained with 
4’-6’-diamido-2-phenylindole dihydrochloride (DAPI) 
(1:10,000 in PBS, Sigma Chemical Co., St. Louis, MO, 
USA). Coverslips were finally mounted with Mowiol in 
PBS for observation. Fluorescence signals were analyzed 
by conventional fluorescence or by scanning cells in 
series of 0.5 µm sequential sections with an ApoTome 
System (Zeiss, Oberkochen, Germany) connected with an 
Axiovert 200 inverted microscope (Zeiss); image analysis 
was then performed by the Axiovision software (Zeiss). 
The percentage of vimentin, α-SMA and Ki67-positive 
cells was analyzed counting for each treatment a total of 
500 cells, observed in ten microscopic fields randomly 
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taken from three different experiments. Results have been 
expressed as mean values ± Standard Deviation (SD).
Flow cytometry analysis
For the analysis of cell cycle, each culture was 
plated sparsely at P1 so that it did not touch each other and 
did not reach contact inhibition. Cells were trypsinized, 
pelleted and resuspended in 70% ethanol in PBS, and 
stored at 4°C overnight. Then they were washed with PBS, 
resuspended in propidium iodide (PI) staining solution (50 
mg/ml) and RNAse A (100 Kunitz/ml) (Miltenyi Biotec 
GmbH, Bergisch Gladbach, Germany) and incubated in 
the dark for 40 minutes at room temperature. 
For the surface antigen expression, the MoAbs 
used were: CD146-PE, human (Miltenyi Biotec GmbH), 
CD90.2-APC (Miltenyi Biotec GmbH), CD44-FITC 
(Becton, Dickinson and Company, Franklin Lakes, New 
Jersey), CD105-APC (Miltenyi Biotec GmbH) and 
CD34-PE (Miltenyi Biotec GmbH). Negative control was 
performed using the HaCaT, spontaneously immortalized 
human keratinocyte cell line. 
For this assay the cells were harvested and 
stained according to the manufacturer instructions. Each 
measurement contained at leats 30,000 cells collected with 
MACSQuant® Analyzer flow cytometer (Miltenyi Biotec 
GmbH) and analysed with MACSQuantify® software 
(Miltenyi Biotec GmbH). 
In vitro differentiation and proliferation of 
tendon-derived cells 
Cellular samples were then passed and further 
cultured in specific differentiation media for osteocytes, 
chondrocytes or adipocytes. Differentiation of each sample 
was performed using specific media to promote osteogenic, 
chondrogenic and adipogenic differentiation, respectively. 
Cells were cultured for osteogenic differentiation in hMSC 
Osteogenic Diff BulletKit (LONZA, Basel Switzerland), 
for chondrogenic differentiation in hMSC Chondrogenic 
Diff BulletKit and TGF-β3 for hMSC Chondro (LONZA, 
Basel Switzerland), and for adipogenic differentiation 
in hMSC Adipogenic Diff BulletKit (LONZA, Basel 
Switzerland), as previously described [43].
In order to evaluate their possible influence on in 
vitro cell differentiation, cultures were subjected to ESWT 
as recently described [11-13], using an electromagnetic 
shock wave generator MODULITH® SLK (STORZ 
MEDICAL AG; Tägerwilen, Switzerland), at a dose of 
shock waves 0.14 mJ/mm2 energy level and 1000 impulses 
as previously described [11-13], whereas the control group 
was maintained in the same culture conditions, consisting 
in conventional or differentiation media, without previous 
shock wave exposure. Shock wave intensity and energy 
levels were previously selected [11-13] in order to 
maximize the therapeutical effects without significantly 
decrease the cell viability. 
A cryogenic vial (Corning Incorporated, NY, USA) 
containing a cell suspension with 1.106 cells/ml was placed 
on shock wave generator with a coupling gel (Aquasonic 
100; Parker Laboratories, Fairfield, New Jersey, USA) to 
minimize the loss of shock wave energy at the interface 
between the head of the device and the cryovial. The tube 
was placed exactly in the focus of the application pad 
under ultrasonographic control.
In particular, cells destined to morphological/
cytochemical and molecular analysis were grown 2-3 days 
in the Differentiation Media (DM), detached and exposed 
to ESWT, and further cultured 3 weeks in DM. Controls 
were grown 3 weeks in conventional or differentiation 
media, without shock wave exposure. According with 
our previous reports [11, 12], cells evaluated for Ki67 
proliferation and Scx early differentiation marker were 
grown 12 days after ESWT in conventional medium, 
whereas controls were grown the same days without 
previous shock wave exposure. 
Morphological analysis
The morphological analysis of human tendon-
derived cells -either from healthy ST or ruptured AT- was 
performed during cell growth in specific differentiation 
media, following ESWT, using an Axiovert 200 inverted 
microscope (Zeiss, Oberkochen, Germany) equipped with 
Axiovision image analysis system (Zeiss). 
transmission electron microscopy
Human primary cultures, isolated and treated as 
above, were fixed with 2% glutaraldehyde in PBS at 
4-C. Samples were postfixed in 1% osmium tetroxide 
in veronal acetate buffer (pH 7.4) for 1 hour at 25°C, 
stained with uranyl acetate (5 mg/ml) for 1 hour at 25°C, 
dehydrated in acetone and embedded in Epon 812 (EMbed 
812, Electron Microscopy Science, Hatfield, PA, USA). 
Ultrathin sections, unstained or poststained with uranyl 
acetate and lead hydroxide, were examined under a 
Morgagni 268D transmission electron microscope (FEI, 
Hillsboro, OR, USA), equipped with a Mega View II 
charge-coupled device camera (SIS, Soft Imaging System 
GmbH, Munster, Germany) and analyzed with AnalySIS 
software (SIS, Soft Imaging System GmbH, Munster, 
Germany).
Quantitative evaluation of osteogenic and 
adipogenic differentiation markers
The evaluation of ESWT potential to influence 
differentiation of tendon-derive cells grown in specific 
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media (as described earlier) was performed by 
cytochemical staining of typical differentiation markers, 
Oil Red for adipocytes and Alizarin Red for osteocytes. 
In particular, after 3 weeks of culture, ESWT treated/
untreated cells were stained using Oil Red O assay kit 
(Millipore), as indicator of intracellular lipid droplets 
in adipocytes or Alizarin Red S assay kit (Millipore) 
as indicator of mineral depots in osteocytes, following 
manufacturer’s instructions. Digital images were collected 
by a Axiocam (Zeiss) CCD camera and analyzed by the 
Axiovision (Zeiss) software. Background and positive 
levels of staining were defined in control slides. For 
Oil Red and Alizarin Red, samples -observed at a final 
magnification of 320X- were scanned for the whole length 
and at least 10 digital frames were randomly taken for 
each conditions. Values are expressed as percentage of 
positive area/total frame area ± Standard Deviation (SD).
Molecular analysis of chondrogenic, osteogenic, 
adipogenic and tenocytic differentiation
The ESWT potential to influence differentiation of 
tendon-derived cells grown in osteogenic, chondrogenic 
and adipogenic media was further tested, determining 
by qRT-PCR the expression of specific genes activated 
in response to differentiative stimuli. Oligonucleotide 
primers for target genes and for the housekeeping 
gene were chosen with the assistance of the Oligo 5.0 
computer program (National Biosciences, Plymouth, 
MN) and purchased from Invitrogen. The following 
primers were used: for alkaline phosphatase, ALP target 
gene: 5’-CAAGGACGCTGGGAAATCTGT-3’ (sense), 
5’-AGGGGGCATCTCGTTGTCT-3’ (anti-sense); for 
Bone Gamma-Carboxyglutamate (Gla) Protein, BGLAP 
target gene: 5’-CCTCACACTCCTCGCCCTAT-3’ 
(sense), 5’- GCTTGGACACAAAGGCTGC-3’ (anti-
sense); for the Run-related transcription factor 2, RUNX2 
target gene: 5’- GAACCCAGAAGGCACAGACA-3’ 
(sense), 5’-GCGGGACACCTACTCTCATAC-3’ 
(anti-sense); for the transcription factor, SOX9 
target gene: 5’-CCCCCAACGCCATCTTCAA-3’ 
(sense), 5’-CTGGGATTGCCCCGAGTG-3’ (anti-
sense); for the type II collagen, COL2A target 
gene: 5’- ACACTGGGACTGTCCTCTGCGA -3’ 
(sense), 5’-CCTTTGGTCCTGGTTGCCCACTG-3’ 
(anti-sense); for the peroxisome proliferator 
activator receptor gamma, PPARγ target gene: 
5’-GGAAAGACAACAGACAAATCACCAT-3’ 
(sense), 5’-ACCTCTTTGCTCTGCTCCTG-3’ (anti-
sense); for the transcription factor scleraxis A, SCXA 
target gene: 5’-CGAGCGAGACCGCACCAACA-3’ 
(sense), 5’-CGTTGCCCAGGTGCGAGATGTAG-3’ 
(anti-sense); for the 18S rRNA housekeeping gene: 
5’-AACCAACCCGGTCAGCCCCT-3’ (sense), 
5’-TTCGAATGGGTCGTCGCCGC-3’ (antisense). For 
each primer pair, we performed no-template control and 
noreverse- transcriptase control (RT negative) assays, 
which produced negligible signals. RNA was extracted 
using the TRIzol method (Invitrogen, Carlsbad, CA) 
according to manufacturer’s instructions and eluted with 
0.1% diethylpyrocarbonate (DEPC)-treated water. Total 
RNA concentration was quantitated by spectrophotometry 
and the quality was assessed by measuring the optical 
density ratio at 260/280 nm. RNA samples were stored 
at -80°C. After denaturation in DEPC-treated water at 
70°C for 10 min, 1 µg of total RNA was used to reverse 
transcription using iScriptTM cDNA synthesis kit (Bio-
Rad) according to manufacturer’s instructions. Real-
time PCR was performed using the iCycler Real-Time 
Detection System (iQ5 Bio-Rad) with optimized PCR 
conditions. The reaction was carried out in 96-well 
plate using iQ SYBR Green Supermix (Bio-Rad) adding 
forward and reverse primers for each gene and 1 µl of 
diluted template cDNA to a final reaction volume of 
15 µl. All assays included a negative control and were 
replicated three times. The thermal cycling programme 
was performed as follows: an initial denaturation step at 
95°C for 3 min, followed by 45 cycles at 95°C for 10 sec. 
and 60°C for 30 sec. Real-time quantitation was performed 
with the help of the iCycler IQ optical system software 
version 3.0 a (Bio-Rad), according to the manufacturer’s 
manual. The relative expression of the housekeeping gene 
was used for standardizing the reaction. The comparative 
threshold cycle (Ct) method was applied to calculate the 
fold changes of expression compared to control cells. 
Results are reported as mean ± SD from three different 
experiments in triplicate.
statistical analysis
To compare variables that assume normal 
distribution, Student’s T test was calculated. The values 
are expressed as mean ± SD or SE from three independent 
experiments.
To compare variables that do not assume Gaussian 
distribution, Mann-Whitney non-parametric test was 
used. The values are expressed as median ± Interquartile 
Ranges (IR) from three independent experiments. The data 
are represented with the floating bars or Tukey box-and-
whisker plot; the central box represents the values from 
the lower to upper quartile (25th to 75th percentile), the 
middle line represents the median, and the horizontal 
lines represent the minimum and the maximum value of 
observation range.
P values <0.05 were assumed as statistically 
significant.
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